One HDAC inhibitor is already available. Zolinza (Merc) has been out for awhile for the treatment of CTCL. There are probably 9-10 others currently in clinical trials for various cancers. Also Merc is trying to expand Zolinza's indications to include mesothelioma and NSCLC. Good question, its an exciting new area of cancer treatment.